Department of Dermatology, Mayo Clinic, Rochester, Minnesota, United States of America.
Department of Molecular Medicine, Max Planck Institute for Biochemistry, Martinsried, Germany.
PLoS One. 2018 Jul 12;13(7):e0200558. doi: 10.1371/journal.pone.0200558. eCollection 2018.
Focal adhesion kinase (FAK) is an intensely studied non-receptor tyrosine kinase with roles in cancer and other common human diseases. Despite the large interest in FAK, the in vivo contribution of FAK auto-phosphorylation site tyrosine (Y) 397 to FAK function is incompletely understood. To study FAK Y397 in vivo we analyzed mice with 'non-phosphorylatable' Y-to-phenylalanine (F) and 'phospho-mimicking' Y-to-glutamate (E) mutations in the germline. We found that FAK Y397F mice die early during embryogenesis with abnormal angiogenesis like FAK kinase-dead mice. When Y397 is mutated to a glutamate mice survive beyond mid-gestation like mice where Y397 is lost by deletion of FAK exon 15. In culture, defects in proliferation, invasion and gene expression were more severe with the FAK Y397F than with the FAK Y397E mutation despite the inability of FAK Y397E to bind SRC. Conditional expression of FAK Y397F or Y397E in unchallenged avascular epidermis, however, resulted in no appreciable phenotype. We conclude that FAK Y397 is required for the highly dynamic tissue remodeling during development but dispensable for normal homeostasis of avascular epidermis. In contrast to the Y397F mutation, FAK Y397E retains sufficient biological activity to allow for development beyond mid-gestation.
黏着斑激酶(FAK)是一种研究非常深入的非受体酪氨酸激酶,在癌症和其他常见人类疾病中都有作用。尽管人们对 FAK 非常感兴趣,但 FAK 自身磷酸化位点酪氨酸(Y)397 对 FAK 功能的体内贡献还不完全清楚。为了在体内研究 FAK Y397,我们分析了具有种系中 Y 到苯丙氨酸(F)和 Y 到谷氨酸(E)突变的“不可磷酸化”和“磷酸模拟”的 FAK Y397 的小鼠。我们发现,FAK Y397F 小鼠在胚胎发生早期死亡,具有类似于 FAK 激酶缺失小鼠的异常血管生成。当 Y397 突变为谷氨酸时,小鼠可以存活到妊娠中期以后,就像 FAK 外显子 15 缺失导致 Y397 丢失的小鼠一样。在培养中,尽管 FAK Y397E 无法结合 SRC,但与 FAK Y397E 突变相比,FAK Y397F 的增殖、侵袭和基因表达缺陷更为严重。然而,在无血管表皮中条件性表达 FAK Y397F 或 Y397E 并没有导致明显的表型。我们得出的结论是,FAK Y397 是发育过程中高度动态组织重塑所必需的,但对于无血管表皮的正常内稳态是可有可无的。与 Y397F 突变不同,FAK Y397E 保留了足够的生物学活性,允许其发育到妊娠中期以后。